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A B S T R A C T
Objective: The Patient Activation Measure-13 (PAM [35_TD$DIFF]-13) has been found useful for assessing patient
knowledge, skills and conﬁdence in management of chronic conditions, but the empirical evidence from
mental health is sparse. The psychometric properties of PAM in out-patients waiting for treatment in
community mental health centers (CMHC) have therefore been examined.
Methods: A total of 290 adults from two CMHC completed PAM. An exploratory factor analysis was
conducted with 273 patients. Data at baseline and after 4 weeks were used to analyze test-retest
reliability (n = 60) and to analyze the sensitivity to change (n = 51).
Results: The exploratory factor analysis revealed a ﬁt for a two-factor model (Cronbach’s awas 0.86 and
0.67), andwas assessed for a one-factormodel (a = 0.87). The test-retest intraclass correlation coefﬁcient
was 0.76. Sensitivity to change was good with a statistically signiﬁcant activation improvement
(p < 0.001) on patients receiving [36_TD$DIFF]a peer [37_TD$DIFF]co-led-educational intervention (Cohen’s d was 0.85).
Conclusion: PAM has appropriate and acceptable psychometric properties in mental health settings.
Practice implications: Assessing activation before treatment might be useful for scheduling the delivery
of mental health services as well as evaluating educational interventions aimed at improving patient
engagement in mental health.
 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, the Patient Activation Measure-13 (PAM [35_TD$DIFF]-13)
has come to play a major role in assessing a person’s ability to
engage with his or her health behaviour. Patient activation
speciﬁes the level of patients’ engagement [1,2] and may
contribute to better self-management [3], higher engagement in* Corresponding author at: [21_TD$DIFF] epartment [22_TD$DIFF]of [23_TD$DIFF]Research [24_TD$DIFF]and [25_TD$DIFF] evelopment, Division of
Psychiatry, St. Olavs University Hospital, [26_TD$DIFF]P [27_TD$DIFF]O [28_TD$DIFF]Box [29_TD$DIFF]3008 Lade, [30_TD$DIFF]NO- [31_TD$DIFF]7441, Trondheim,
Norway.
E-mail addresses: inger.elise.opheim.moljord@stolav.no (I.E.O. Moljord),
mariela.lara@stolav.no (M.L. Lara-Cabrera).
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nd/4.0/).treatment [2,3], and greater patient satisfaction [4,5]. Patient
activation is in addition associated with better health outcomes
[2]. The Patient Activation Measure-13 (PAM [35_TD$DIFF]-13), developed by
Hibbard et al. [4] from the 22-item version [1], ascertains health
engagement and thereby self-reported knowledge, skills, beha-
viours and conﬁdence for self-management of health and chronic
diseases. Previous research has mostly examined patient activa-
tion among adults with chronic conditions and in primary care
settings [6–14]. There are a few empirical studies addressing
patient activation among mental health populations [15–22],
revealing that patients with depression scored low on patient
activation [15,16,22] and quality of life [16]. Patient activation has
also been positively related to chronic self-management among
patients with psychotic disorders [19,20]. Patients with a higharticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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symptoms, greater recovery attitudes and medication adherence
[18]. Although serious chronic mental health conditions share
similarities with other mental health diseases, patient activation
among persons with less serious mental illness has not been
speciﬁcally explored. Additional research has therefore been
suggested [18]. Reliable, sensitive and valid measures are thus
needed in mental health services when patient activation and
engagement in treatment is investigated.
The validation of PAM[38_TD$DIFF]-13 has been examined across adults with
chronic conditions [6–8], among multimorbid older adults [12], in
a surgery setting [10], in neurological populations [11,23], among a
diabetes population [9], on patients with osteoarthritis [14], in a
primary care setting [13] and for chronic disease in rural settings
[24]. PAM has in the early stage been validated via Rasch
psychometric methods, and a unidimensional probabilistic Gutt-
man-like scale was constructed [25] with a demonstrated validity
and reliability [1,6,9,11]. PAM has also been more recently
validated with use of an explorative principal component factor
analysis, which reported a unidimensional model [13], while a
conﬁrmatory analysis reported a three-factor model [10].
Remarkably, previous research has only examined the test-
retest reliability with Rasch models [9] and with test-retesting on
patients with chronic conditions [8,26]. Green et al. [18] found a
robust test-retest reliability on an adapted PAM. Thus, to our
knowledge, the test-retest reliability of the original PAM is still a
relatively unstudied area in mental health, and the evidence of[(Fig._1)TD$FIG]
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Fig. 1. StudyPAM’s responsiveness is sparse. The responsiveness is, however,
reported on a modiﬁed PAM version with limited data from people
with chronic mental health conditions (n = 30) [18]. Consequently,
the present study evaluated the factor structure, inter-item
reliability, test-retest reliability and the sensitivity to change of
PAM. The research was done in a clinical mental health outpatient
population with a wide spectrum of mental health problems.
2. Methods
2.1. Study design and participants
The present study was conducted at two Community Mental
Health Centers (CMHC) in mid-Norway with data collected from
three clinical trials and one implementation study aiming to
improve patient participation in mental health services. Inclusion
criteria were the participants were in need of treatment at the
CMHC and were on the waiting list for out-patient or in-patient
treatment. Participants were also required to be at least 18 years
old and have a ﬂuent understanding of the Norwegian language. Of
626 patients eligibly participant, 460 patients were reached and
invited to participate (63%) (See Fig. 1).
A total of 290 patients between 18 and 70 years old (mean age
of 36.77, 61.4% women) consented to participate and completed
the baseline questionnaires. The population comprise patients
with less serious mental illness waiting for out-patient treatment
from ﬁve general out-patients unit (n = 237, 82.0%), and patients 
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Table 1
Socio-demographic and clinical data.
All patients (n=290) Test-retest (n=60) Responsiveness
(n=51)
Age (SD) 36.77 (12.59) 36.15 (12.80) 38.27 (11.63)
Female (%) 178 (61.4) 41 (68.3) 31 (60.8)
Married, cohabitant (%) 118 (40.8) 26 (43.3) 23 (45.1)
ICD-10 diagnosis
Alcohol related, F 10, n (%) 3 (1.0) 1 (1.7) 0
Schizophrenia related, F 20–29, n (%) 37 (12.8) 1 (1.7) 0
Mood disorders, F 30–39, n (%) 85 (29.3) 19 (31.7) 19 (37.3)
Neurotic disorders, F 40–48, n (%) 74 (25.5) 22 (36.7) 12 (23.5)
Behavioural syndromes, F 50–59, n (%) 10 (3.4) 3 (5.0) 3 (5.9)
Personality disorders, F 60–69, n (%) 28 (9.7) 6 (10.0) 7 (13.7)
Mental retardation, F 70, n (%) 1 (0.3) 0 1 (2.0)
Behavioural and emotional disorders, F 90–98, n (%) 23 (7.9) 4 (6.7) 5 (9.8)
Others 24 (8.3) 4 (6.7) 4 (7.8)
Friendship
No friends, n (%) 37 (12.8) 7 (11.7) 8 (15.7)
One friend, n (%) 116 (40.3) 18 (30.0) 13 (25.5)
Two to ﬁve, n (%) 118 (41.0) 32 (53.3) 24 (47.1)
More than ﬁve, n (%) 17 (5.9) 3 (5.0) 6 (11.8)
Education
Primary, n (%) 62 (22.4) 13 (21.7) 22 (43.1)
Secondary, n (%) 148 (53.4) 27 (45.0) 15 (29.4)
Bachelor’s degree or higher, n (%) 67 (24.2) 20 (33.3) 14 (27.5)
Employment status
Full-time, n (%) 61 (21.5) 19 (32.2) 11 (21.6)
Part-time, sick leave or rehabilitation 96 (33.8) 23 (39.0) 17 (33.3)
Student, n (%) 37 (13.0) 7 (11.9) 4 (7.8)
Unemployed, n (%) 30 (10.6) 2 (3.4) 7 (13.7)
Retired, n (%) 10 (3.5) 4 (6.8) 7 (13.7)
Disability pension, n (%) 39 (13.7) 2 (3.4) 0
Other, n (%) 11 (3.9) 2 (3.4) 5 (0.8)
Living with someone
Alone, n (%) 95 (32.9) 16 (27.1) 19 (37.3)
Family, n (%) 163 (56.4) 36 (61.0) 20 (39.2)
With others, n (%) 31 (10.7) 7 (11.9) 12 (23.5)
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patient unit (n = 53, 18.0%). Clinical and socio-demographic data of
the total sample, as well as for the test-retest and the responsive-
ness subsamples, are presented in Table 1.
Among the participants waiting for out-patient treatment, a
randomly selected subsample (n = 60) completed the question-
naire twice within amonth. This subsample did not receive neither
any intervention nor treatment during the waiting time. It was
therefore not expected that any signiﬁcant changes would be
observed during this period.
The responsiveness subsample (n = 51) [39_TD$DIFF]exists of an implemen-
tation study of consecutive patients waiting for out-patient
treatment. They received [40_TD$DIFF]a peer co-led intervention consisting
of 8 h of educational group followed by an individual treatment
planning session. The information was about available treatment
options, patients’ rights, self-management strategies and ways to
early engage and participate in the treatment. They completed the
questionnaires at baseline and after 4 weeks (before and after the
intervention). It was hypothesized that the intervention would
improve patients’ knowledge, conﬁdence and skills; hence,
increased activation during this period was expected.
2.2. Recruitment, procedure and data collection
Health personnel at each unit identiﬁed potentially eligible
participants on the waiting list at the CMHC. The identiﬁed
patients who were able to reach received both verbal information
and an invitation letter with information about the study. They
could accept by directly contacting the researchers or by mail,
using the return envelope. Those who accepted were contacted bya researcher for an inclusion appointment, wherewritten informed
consent was obtained and the ﬁrst questionnaires were collected.
Test-retest and responsiveness subsamples responded to the
follow-up questionnaire by mail. The data collection began in
June 2009 and was completed in December 2012.
2.3. Measures
2.3.1. Demographic data
Demographic data included gender, age, employment status,
education, living situation,marital status, friendship status and the
ICD-10 diagnosis (International Classiﬁcation of Diseases, version
10 [27]). Diagnoses were obtained from the registry data. The
patients who were waiting for in-patient treatment were all
diagnosed and had received previous treatment before they were
included in the project. Diagnoses of patients waiting for out-
patient treatment were obtained and set after the treatment had
started.
2.3.2. Patient Activation Measure-13
The translated Norwegian PAM[38_TD$DIFF]-13 [26] was used to assess
activation in the present study. The 13 items have four possible
response options ranging from (1) strongly disagree to (4) strongly
agree, and an additional ‘‘not applicable’’ option. To calculate the
total PAM score, the raw score is divided by the number of items
answered (excepting non-applicable items) and multiplied by
13. Then, this score is transformed to a scale with a theoretical
range 0–100, based on calibration tables, with higher PAM scores
indicating higher patient activation [28]. The raw scores can be
converted into four activation levels: 1 (47.0) not believing
I.E.O. Moljord et al. / Patient Education and Counseling 98 (2015) 1410–1417 1413activation important, 2 (47.1–55.1) a lack of knowledge and
conﬁdence to take action, 3 (55.2–67.0) beginning to take action
and 4 (67.1) taking action [4,28]. These levels may also be used as
cut-offs [13,28]. Patients received explicit oral and written
instructions that the questions referred to mental health.
2.4. Ethics
The Regional Committee forMedical andHealth Research Ethics
in Mid-Norway (No. 4.2009.77 and No. 2009/1704) approved the
trials in accordance with the Helsinki Declaration. The clinical
trials registrations are NCT00967265, NCT01601587 and
NCT01133587. All participants signed consent forms before taking
part in the data collection. Patients did not receive any payment for
participation.
2.5. Statistical analysis
Item descriptive statistics were calculated. The percentage of
missing data and non-applicable answers were calculated for each
item. Floor and ceiling effectswere considered present ifmore than
15% of the patients achieved the lowest or highest possible score.
Questionnaires withmore than threemissing itemswere excluded
from the remaining analyses.
To investigate the factor structure in PAM, an exploratory
Principal Component Analysis (PCA) was conducted (missing
values were excluded pairwise). A one-component solution was
explored and compared to alternative solutions obtained by
extracting components with eigenvalues greater than 1, and by
using oblimin rotation. Inter-item reliability was calculated by
using Cronbach’s a.
Test-retest reliability (n = 60) was calculated via the intraclass
correlation coefﬁcient (ICC) based on a two-way random-effects
model for the total scale score and for each item. An ICC exceeding
0.75 indicates excellent test-retest reliability, values between
0.40 and 0.75 point to fair to good reliability, whereas less than
0.4 indicates poor test-retest reliability. To analyze the mean
differences from baseline to follow-up, we also performed a paired
t-test (for the total scale) and a Wilcoxon signed-rank test (for
individual items).
These two last tests were also performed to assess changes on
patients before and after an educational intervention (responsive-
ness sample, n = 51). Effect sizes were interpreted according to
Cohen’s guidelines [29]: small (0.20), medium (0.50) and large
(0.80). To compare the change between the responsiveness
(intervention group), and the test-retest (considered as a control
group) subsamples, a 2  2 repeated measures ANOVA was
[(Fig._2)TD$FIG]
Fig. 2. Responses across missing, not-applicaperformed, with time (baseline, 1 month) and group (intervention,
control) as independent variables.
The statistical analyses were carried out with IBM corp. SPSS,
version 22 [30]. For all analyses, a p-value less than 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. PAM and psychometric properties
The missing responses were very low, only four items from two
different patients. The category ‘not applicable’ was used in all
items, from 0.7 to 36.2%, where the percentage per itemwas below
7%, except for items 4 (36.2%), 7 (22.1%) and 10 (13.4%) (Fig. 2). All
items excepting 9, 12 and 13 showed ceiling effect (range 19.8–
65.8%). Only items 9 and 13 showed ﬂoor effect (29.2 and 25.2%,
respectively). Results are shown in Table 2. After excluding
patients with more than three missing items (n = 17), the mean
activation score was 51.93 (SD = 14.21; n = 273) (Table 2).
3.1.1. Factor structure and inter-item reliability
There were signiﬁcant positive correlations between all the
patient activation items (0.12–0.58, p < 0.05 to < 0.001), with a
mean inter-item correlation of 0.33. The PCA was deemed
adequate data for the analysis (Kayser–Meyer–Oklin value = 0.88;
Bartlett’s test of sphericity x2 = 666.57, df = 78, p < 0.001). Results
are shown in Table 3.
The one-component solution explained 37.94% of the variance,
and all items showed factor loadings greater than 0.47.
When components with eigenvalue exceeding 1 were
extracted, a bi-factorial solution was obtained: component
1 explained 37.94% and component 2 explained 10.13% of the
variance. A bi-factorial solution explained thus totally 48.07% of
the variance. After oblimin rotation, the ﬁrst component, labelled
‘knowledge and self-conﬁdence’, was represented by items 4–13
(all factor loadings greater than 0.46). The second component
(items 1–3), with factor loadings greater than 0.59, was labelled
‘believing active role important and responsibility’. The two
components revealed a correlation of 0.41.
Cronbach’s a for the whole scale was 0.87. In the two-factor
model, it was 0.86 and 0.67, respectively.
3.1.2. Test-retest reliability
Sixty out of 64 patients provided valid test-retest data at
1 month (Table 4). The patients in this subsample did not differ
signiﬁcantly from the total sample in the activation level in the ﬁrst
assessment (p = 0.60). There were no signiﬁcant differencesble and agreement categories (n = 290).
Table 2
Item descriptives (n=290).
Items (range 1–4) Mean (SD) Skewness M, n NA,
n (%)
Floor, n (%) Ceiling, n (%)
1. When all is said and done, I am the person who is responsible for managing
my health condition
3.35 (0.75) 1.17 0 2 (0.7) 10 (3.5) 137 (47.6)
2. Taking an active role in my own health care is the most important factor in
determining my health and ability to function
3.58 (0.68) 1.81 0 6 (2.1) 7 (2.5) 187 (65.8)
3. I am conﬁdent that I can take actions that will help prevent or minimize
some symptoms or problems associated with my health condition
2.92 (0.80) 0.42 1 2 (0.8) 14 (4.9) 67 (23.3)
4. I know what each of my prescribed medications does 3.16 (0.92) 0.80 1 104 (35.9) 11 (5.9) 85 (45.4)
5. I am conﬁdent I can tell when I need to go get medical care and when I can
handle a health problem myself
2.89 (0.92) 0.50 0 18 (6.2) 25 (9.2) 76 (27.9)
6. I am conﬁdent I can tell my health provider the concerns I have even when
he or she does not ask
2.89 (0.90) 0.40 0 5 (1.7) 21 (7.4) 79 (27.7)
7. I am conﬁdent I can follow through on the medical treatment I need to do
at home
3.14 (0.96) 0.90 1 63 (21.7) 20 (8.8) 101 (44.7)
8. I understand the nature and causes of my health condition 2.71 (0.97) 0.26 0 4 (1.4) 37 (12.9) 68 (23.8)
9. I know the different medical treatment options available for my health
condition
2.20 (0.99) 0.31 0 6 (2.1) 83 (29.2) 32 (11.3)
10. I have been able to maintain the lifestyle changes I have made for my
health
2.71 (0.95) 0.21 0 39 (13.4) 29 (11.6) 58 (23.1)
11. I know how to prevent further problems with my health condition 2.60 (0.95) 0.08 1 6 (2.1) 38 (13.4) 56 (19.8)
12. I am conﬁdent I can ﬁnd a solution when new situations or problems
arise with my health condition
2.40 (0.87) 0.12 0 11 (3.8) 41 (14.7) 30 (10.8)
13. I am conﬁdent I can maintain lifestyles changes, like diet and exercise,
even during times of stress
2.27 (0.96) 0.19 0 12 (4.1) 70 (25.5) 31 (11.2)
Activation from 0 to 100, all items
(n=273)a
51.93 (14.21) 0.42 0
M: missing; NA: not applicable; SD: standard deviation.
a Seventeen patients were excluded because they showed more than three missing items.
Table 4
Test-retest results (n=60).
Item n Baseline mean
(SD)
1 Month mean
(SD)
pa ICCb
Allc 60 52.64 (10.9) 52.70 (12.2) 0.956 0.750
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1month (52.70, SD = 12.2). The two components derived from PCA
neither showed signiﬁcant changes.
The test-retest reliability using ICC was good (0.76) for the
entire scale and varied from fair to excellent for all items. The
lowest ICC value was 0.44 (item 12) and the highest ICC was 0.89
(item 4).
3.1.3. Responsiveness
Fifty-one consecutive patients provided data before and after
participating in an educational intervention (1 month). Their
activation level in the ﬁrst assessmentwas signiﬁcantly lower than
the total population (p  0.001).
As shown in Table 5, these patients signiﬁcantly improved their
activation level between the ﬁrst (46.04, SD = 10.7) and the second
assessment (55.87, SD = 12.9), showing a large effect size (d = 0.83,
p  0.001). All items increased after the intervention; eight of themTable 3
Principal component analysis with oblimin rotation (n=273)a.
Item One component Two components
Factor 1
(loadings)
h2 Factor 1
(loadings)
Factor 2
(loadings)
h2
1 0.474 0.224 0.096 0.851 0.667
2 0.555 0.308 0.052 0.761 0.615
3 0.553 0.306 0.172 0.586 0.455
4 0.646 0.418 0.517 0.231 0.418
5 0.690 0.476 0.456 0.385 0.499
6 0.572 0.327 0.539 0.088 0.337
7 0.678 0.460 0.585 0.181 0.462
8 0.585 0.342 0.712 0.142 0.444
9 0.610 0.372 0.793 0.221 0.535
10 0.651 0.424 0.627 0.080 0.441
11 0.704 0.495 0.731 0.010 0.541
12 0.673 0.453 0.709 0.005 0.500
13 0.570 0.325 0.538 0.087 0.335
Cronbach’s a 0.87 0.86 0.67
a Values in bold indicate loadings higher than 0.45.have statistically signiﬁcant changes (p  0.005). When the two
components identiﬁed by means of PCA were analyzed separately,
they both showed a signiﬁcant improvement (p  0.001 and
p = 0.014, respectively), although the effect is greater on the ﬁrst
factor (d = 0.79 and 0.45, respectively).
A repeatedmeasures ANOVAwith time (baseline, 1 month) and
group (intervention versus test-retest subsample, considered as a
control group) as independent variables yielded a signiﬁcant
interaction effect (F = 22.32, p < 0.001), with a higher improve-
ment in the intervention group.Factor 1
(items 4–13)d
60 26.70 (4.8) 26.67 (4.9) 0.948 0.764
Factor 2
(items 1–3)e
60 10.10 (1.5) 10.08 (1.7) 0.931 0.555
1 59 3.47 (0.7) 3.56 (0.6) 0.134 0.565
2 58 3.74 (0.6) 3.62 (0.7) 0.176 0.505
3 59 2.95 (0.7) 2.95 (0.8) 0.983 0.598
4 32 3.03 (0.9) 3.03 (0.9) 1.000 0.889
5 54 2.91 (0.7) 2.85 (0.8) 0.405 0.797
6 60 2.88 (0.9) 2.92 (0.9) 0.695 0.694
7 36 3.39 (0.7) 3.25 (1.0) 0.371 0.469
8 59 2.73 (0.9) 2.71 (0.8) 0.903 0.545
9 57 2.33 (0.9) 2.35 (0.9) 0.854 0.684
10 50 2.62 (0.8) 2.76 (0.9) 0.216 0.593
11 59 2.53 (1.0) 2.61 (0.9) 0.348 0.737
12 57 2.37 (0.8) 2.44 (0.7) 0.417 0.436
13 57 2.33 (1.0) 2.26 (0.9) 0.537 0.690
a p-Value for the difference between pre- and post-scores, using paired t-test for
the total score and the two factors, and Wilcoxon signed-rank test for the single
items.
b Intra-class correlation.
c Range 0–100.
d Range 10–40.
e Range 3–12.
Table 5
Responsiveness to intervention (n=51).
Item n Baseline mean (SD) 1 Month mean (SD) pa
Allb 51 46.04 (10.7) 55.87 (12.9) <0.001
Factor 1
(items 4–13)c
51 23.97 (5.3) 28.23 (5.5) <0.001
Factor 2
(items 1–3)d
51 9.26 (1.6) 9.98 (1.7) 0.014
1 50 3.26 (0.6) 3.48 (0.7) 0.019
2 50 3.34 (0.6) 3.64 (0.6) 0.006
3 48 2.75 (0.7) 2.88 (0.8) 0.283
4 23 2.87 (0.8) 3.22 (1.0) 0.021
5 44 2.70 (0.9) 2.86 (0.8) 0.198
6 50 2.80 (0.8) 2.98 (0.9) 0.167
7 31 2.84 (0.9) 3.39 (0.9) 0.002
8 48 2.33 (0.9) 2.85 (0.9) 0.002
9 48 1.73 (0.7) 2.73 (0.8) 0.000
10 36 2.53 (0.8) 2.72 (0.6) 0.265
11 46 2.35 (0.7) 2.78 (0.7) 0.000
12 45 2.31 (0.8) 2.67 (0.8) 0.020
13 46 2.09 (0.8) 2.30 (0.7) 0.068
a p-Value for the difference between pre- and post-scores, using paired t-test for
the total score and the two factors, and Wilcoxon signed-rank test for the single
items.
b Range 0–100.
c Range 10–40.
d Range 3–12.
I.E.O. Moljord et al. / Patient Education and Counseling 98 (2015) 1410–1417 14154. Discussion and conclusion
4.1. Discussion
The aim of the present study was to investigate the
psychometric properties of PAM[38_TD$DIFF]-13 in an out-patient population
waiting for mental health treatment. The results indicate that the
instrument had acceptable psychometric properties.
4.1.1. Data quality
The data were of good quality with a low number of missing
values (only two persons with a total of four items). The response
rate was high, perhaps because the questionnaires were answered
when the patients were at the centres. The use of the ‘not
applicable’ category was comparable to previous studies [6,8,9],
and only three items scored more than 10% in this category (items
4, 7 and 10). These items refer to medications, medical treatment
and life style changes, respectively, and therefore this result is
reasonable in out-patients who were waiting for treatment and
had not yet started with medication or psychotherapy.
The mean scores varied from 2.20 (‘knowledge’, item 9) to 3.58
(‘taking an active role in my health’, item 2). Floor effects were
observed in two items (9 and 13), but ceiling effects were large
(10 out of 13 items, mean ceiling = 35%). A total of four items (1, 2,
4 and 7) had more than 40% of values in the ‘‘strongly agree’’
category. The large ceiling effect is comparable to previous
validation studies by Zill et al. [6] but inferior to studies by
Brenk-Franz et al. [13] and Maindal et al. [9]. The ﬂoor and ceiling
effects may reduce responsiveness to the questionnaire. In our
study, however, those items showing a high ceiling effect have also
demonstrated a signiﬁcant sensitivity to change among patients
receiving the intervention.
4.1.2. Factor analysis and psychometric properties
The PCA yielded two components with eigenvalues higher than
1, labelled ‘knowledge and self-conﬁdence’ (items 4–13) and
‘believing active role important/responsibility’ (items 1–3). This
bi-factorial solution has not been identiﬁed in previous research
[4,6,9–11,13]. Composition of the components seems to discrimi-
nate a more generalized notion of responsibility and involvement
(factor 2) from more speciﬁc and contextualized activationbehaviours (factor 1), although an order effect cannot be ruled
out (factor 2 comprises the ﬁrst three items). Studies that used the
Rasch model have supported the unidimensionality of the scale by
Zill et al. [6], Stepleman et al. [11] and Packer et al. [23]. When PCA
has been used [13,23], all items showed high factor loadings in the
monofactorial solution and the explained variance was around
40%, similar to the value obtained in this study. However, in both
studies the authors state that additional factors could be
considered. Skolasky et al. [10] performed a conﬁrmatory factor
analysis in a sample presenting for elective lumbar spine and found
that a three factor solution yielded the best ﬁt.We cannot provide a
deﬁnitive conclusion about the factor structure when using
exploratory factor analysis, but our results are not incongruent
with a one-component solution (high loadings of all items, good
inter-item reliability). Future conﬁrmatory analyses in mental
health samples should clarify this issue.
Differences in the samples studied (chronic or acute, somatic or
mental disorders, different cultural backgrounds, etc.) could result
in different factor structures. European studies which have used
Rasch analysis have observed discrepancies regarding the devel-
opmental nature of the model derived from the original USA
validation data [6,23].
The test-retest reliability following a 1-month interval showed
good ICC results. The long interval was important for reducing
potential recall bias, but this may also be a source of bias, e.g.
running the risk that scores are inﬂuenced by signiﬁcant changes in
the participants’ situation. Regardless, stability was observed in all
items, without signiﬁcant changes from pre- to post-intervention,
andwe can therefore assume that the time interval did not bias the
results. In previous studies, Skolasky et al. [[41_TD$DIFF] 0] observed an
excellent ICC on patients with lumbar spine surgery at 1 week.
However, other studies with speciﬁc populations and longer test-
retest periods have found that PAM’s stability may ﬂuctuate over
time [31]. In the case of mental health, Green et al. [ [42_TD$DIFF]18] observed a
good stability at 14 weeks (Pearson’s r = 0.74). The present study
supports this result, but further research in mental health samples
is needed to conﬁrm these ﬁndings.
The group that received the educational intervention showed a
signiﬁcant and strong improvement in activation 1 month later.
When this change was compared to the test-retest group
(considered as a control group) by means of ANOVA, the difference
was highly signiﬁcant in favour of the intervention group.
However, the possibility of a regression to the mean cannot be
ruled out, as this subsample was not randomly but consecutively
selected from the total sample, and it showed a signiﬁcantly lower
baseline score. Participants with serious mental disorders in the
randomized trial of Druss et al. [17] also showed a low baseline
score; a signiﬁcant improvement in activation at 6 months was
observed. Green et al. [18], found a similar improvement to the one
observed in our results, in a randomized pilot study on serious
chronic mental disorders (n = 30). Thus, additional randomized
studies are required to conﬁrm these results and explore predictors
of the intervention effect.
4.1.3. Patient activation in mental health
The patient activation mean score in the present study is lower
than previous studies in chronic [6,8–11,13] and surgery samples
[10], but higher than in the Health and Recovery Peer Program
(HARP) [17]. In the context of mental health, a considerable
variability has been observed, but our sample also has a lower
mean activation score (51.93) than participants with depression
[1], anxiety [6], schizophrenia [20] and mixed samples
[18,19]. Deen et al. [32] reported low patient activation (58.9) in
community health centres before intervention, but still higher
than in the present study. Importantly, a selection bias cannot be
ruled out as the participation rate in this study was not 100%.
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could be in part responsible of their low activation. Cultural aspects
could also explain this result.
Assessing PAM is easy, taking only a fewminutes to ﬁll in and to
score, which is important given that the therapist may in addition
use diagnostic and other questionnaires. Using one more tool will
lengthen the duration of the consultation. Given thatmental health
services are facing challenges with respect to lack of treatment
engagement, patient activation may be one important, short and
simple intervention to improve engagement in treatment. A more
clinical explorative focus on activation, with use of one-to-one
consultations, could simultaneously help to provide a more
targeted treatment. In this explorative clinical way, the patients
can be better prepared to adopt positive health behaviours.
The low activation mean score and the improvement in the
responsiveness sample in the present study suggest some
reﬂections. On one side, it describes the activation status of
patients waiting for treatment, and raises concerns about the
appropriateness of the current ‘‘standard of care’’ with the use of
waiting list for mental health treatment [33]. On the other side, it
highlights the importance of the development of interventions to
improve activation in health care setting [2]. This is particularly
important in a mental health setting where patients are expected
to deal with several challenging behaviours and to take actions to
modify or minimize their mental health problems. Simulta-
neously, engaging people in such behavioural changes may be
difﬁcult. Assessment of PAM, with subsequent help to those who
are in need for activation support, may be important to support
readiness to change. Since high scores on PAM positively
inﬂuence health related behaviours [34], it may be important
that patients in mental health receive help to increase their
knowledge, skills and conﬁdence for managing their own health.
Studies on the effect of short interventions focusing on
improving patient activation are emerging with encouraging
results on treatment outcomes [17,32]. However, more research
is needed in this area to gain a better understanding of these
interesting ﬁndings.
4.1.4. Strengths and limitations
The present study provides support for appropriate psycho-
metric properties of the PAM used in a clinical mental health care
setting. Moreover, this study provides evidence supporting the few
investigations on the test-retest reliability properties of the PAM [43_TD$DIFF]-
13 and its sensitivity to detect change.
However, several limitations should be taken into account
when interpreting the present ﬁndings. First, the participation rate
was not optimal (63%), and therefore there is a serious risk of
selection bias. It is not known how many participants[5_TD$DIFF] have
received previous mental health treatment. Differences between
new and experienced patients according to experiences of
treatment may affect activation and should be investigated in
future studies.
The patients were instructed that the questions referred to
mental health issues, however, we cannot be sure that they had
this in mind when they responded to the questionnaires. After the
initiation of this study (June 2009) the validation of an adapted
version of PAM for mental health samples was published [18].
We have not been able to study PAM concurrent validity, and
since we were unable to ﬁnd a validated instrument in Norway
measuring the same or similar activation concepts, we have not
been able to demonstrate validity against a ‘gold standard’. The
population in the present study represents a variety of mental
health problems and severities. However, before generalizing PAM
in mental health research it would be important to investigate
patient activation in other mental health settings, e.g. hospitalized
patients.5. Conclusion
The Norwegian version of PAM[43_TD$DIFF]-13 has an acceptable factorial
validity, test-retest reliability and sensitivity, making it a suitable
clinical and research tool in mental health settings. Our study
expands the scope of PAM, providing support for its use for
understanding activation among out-patients in community
mental health [44_TD$DIFF]centres.
5.1. Practice implications
PAMmay identify key aspects of patient engagement in mental
health care. Knowing patients’ activation levels while they are
waiting for treatment may help to identify potential interventions
for improving the quality of care during the waiting time, e.g.
identifying those with poor engagement, preventing worsening of
the condition, and later helping those with low PAM scores to
engage in their own care. Assessing activation in an early stage
could be useful when planning the treatment to understand how
patients engage in their own health. The PAM is fast to score, and
the clinicians may use the four activation levels as cut-offs for
indication of the patients’ activation involvement. The discussion
of activation and treatment perceptions, as well as concerns about
health, could in addition be important for engaging patients in
mental health treatment.
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